Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0000950170-24-002935

Chief Executive Officer sold 1,664 shares at $0.64 ($1,063)

From the SEC's structured data for this filing

Trades in this filing

Brainard Diana · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-01-04 Sale : show line 1 in the form −1,664 $0.64 $1,063 873,242 D
Open-market sales · 1,664 sh · avg $0.64 · $1,063
Loading xslF345X05/ownership.xml…